Medication-related factors affecting health care outcomes and costs for patients with psoriasis in the United States - 21/08/11
, David Richmond, MA c, Daniel J. Pearce, MD b, Steven R. Feldman, MD, PhD b, c
Reprint requests: Rajesh Balkrishnan, PhD, University of Texas Schools of Public Health and Medicine, RAS-E331, 1200 Herman Pressler, Houston, TX 77030.Houston, Texas, and Winston-Salem, North Carolina
Abstract |
Background |
The impact of psoriasis medication therapy on costs and patient outcomes in large nationally representative samples needs further examination.
Objective |
This study examined the association between factors related to medication use, health status, and health care costs associated with psoriasis in the United States.
Methods |
A cross-sectional cohort study was performed using the 2000 Medical Expenditure Panel Survey database. Information on health care service use, health status (EuroQol-5D instrument), and patient demographics were obtained from the database representing approximately 1.1 million patients with psoriasis. EuroQol was used in the Medical Expenditure Panel Survey.
Results |
Weighted multiple linear regression analysis indicated that use of topical corticosteroid therapy was associated with a decrease in psoriasis-specific health care costs (53.2% lower than average costs vs patients using no medications, P=.022) and better health status (34.0% higher than average scores vs patients using no medications, P=.006).
Conclusions |
We observed an association with topical corticosteroids for treatment of psoriasis on health care outcomes and costs.
Le texte complet de cet article est disponible en PDF.Plan
| This study was conducted in conjunction with the Center for Dermatology Research, Wake Forest University School of Medicine, which is supported by a grant from Galderma Inc. No other funding was obtained for the study. Conflicts of interest: None identified. |
Vol 52 - N° 1
P. 27-31 - janvier 2005 Retour au numéro
Article précédent
- The prevalence of psoriasis in African Americans: Results from a population-based study
- Joel M. Gelfand, Robert S. Stern, Tamar Nijsten, Steven R. Feldman, John Thomas, Joe Kist, Tara Rolstad, David J. Margolis
- Bound volumes available to subscribers
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?